My research focuses on the molecular mechanisms underlying cancer and neurodegenerative diseases, particularly the role of genetics and oxidative stress in disease development. I am interested in how variations in DNA repair pathways (especially base excision repair and nucleotide excision repair) influence the risk of cancers. I am also deeply involved in the development of RNA-based liquid biopsy techniques and microRNA biomarkers for non-invasive cancer diagnostics. In parallel, my work explores the design of multifunctional therapeutic compounds with antioxidant and neuroprotective properties for potential use in Alzheimer’s disease treatment. My approach combines molecular biology, clinical genetics, and pharmacological innovation to support advancements in personalized medicine and targeted therapies.